Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Analyzing Welltower's Performance in the Stock Market

Welltower, a Large-Cap Specialty Real Estate Investment Trust stock, moved 0.8% this morning. Here are some facts about the company that we're keeping an eye on:

  • Welltower has logged a 38.2% 52 week change, compared to 12.1% for the S&P 500

  • WELL has an average analyst rating of buy and is -2.11% away from its mean target price of $195.05 per share

  • Its trailing earnings per share (EPS) is $1.45, which brings its trailing Price to Earnings (P/E) ratio to 131.7. The Real Estate sector's average P/E ratio is 27.31

  • The company's forward earnings per share (EPS) is $1.82 and its forward P/E ratio is 104.9

  • The company has a Price to Book (P/B) ratio of 3.37 in contrast to the Real Estate sector's average P/B ratio is 1.94

  • WELL has reported YOY quarterly earnings growth of -43.7% and gross profit margins of 0.4%

  • The company's free cash flow for the last fiscal year was $1.4 Billion and the average free cash flow growth rate is 3.8%

  • Welltower's revenues have an average growth rate of 10.4% with operating expenses growing at 13.1%. The company's current operating margins stand at 6.6%

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS